These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4062438)

  • 21. Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol.
    Lawson JW; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):72-86. PubMed ID: 6111984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Brevikarin dihydrochloride--a new original anti-arrhythmia agent].
    Denisenko PP; Vinogradova TV; Semenov AA
    Farmakol Toksikol; 1988; 51(2):50-3. PubMed ID: 3378605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The antiarrhythmic activity of glycolysis and Krebs cycle intermediates in early occlusion and reperfusion arrhythmias in rats].
    Balashov VP; Balykova LA; Sedova DG; Belova LA; Sernov LN; Kostin IaV
    Eksp Klin Farmakol; 1994; 57(1):30-2. PubMed ID: 8142859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anion manipulation, a novel antiarrhythmic approach: mechanism of action.
    Curtis MJ; Garlick PB; Ridley PD
    J Mol Cell Cardiol; 1993 Apr; 25(4):417-36. PubMed ID: 8393492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs.
    Podzuweit T; Lubbe WF; Opie LH
    Lancet; 1976 Feb; 1(7955):341-2. PubMed ID: 54744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular arrhythmias associated with coronary artery occlusion and reperfusion in the isolated perfused rat heart: a model for assessment of antifibrillatory action of antiarrhythmic agents.
    Lubbe WF; Daries PS; Opie LH
    Cardiovasc Res; 1978 Apr; 12(4):212-20. PubMed ID: 657177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The actions and clinical use of the newer antiarrhythmic drugs.
    Hayes AH
    Ration Drug Ther; 1972 Jul; 6(7):1-6. PubMed ID: 5085124
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of antiarrhythmic agents on ventricular arrhythmias following myocardial infarct induced with glass beads in dogs (author's transl)].
    Kimoto S; Haruna M; Nakao T; Ueda M
    Nihon Yakurigaku Zasshi; 1981 Sep; 78(3):163-71. PubMed ID: 7327447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitiative comparison of bretylium with other antifibrillatory drugs.
    Bacaner MB
    Am J Cardiol; 1968 Apr; 21(4):504-12. PubMed ID: 5650730
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection by antiarrhythmic drugs against ischemia-induced arrhythmias occurring during coronary artery occlusion in the rat.
    Gerbsch S; Hagen A
    Biomed Biochim Acta; 1987; 46(8-9):S572-5. PubMed ID: 3435514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic effect of newly synthesized compound 44Bu on model of aconitine-induced arrhythmia -- compared to lidocaine.
    Bartosova L; Novak F; Bebarova M; Frydrych M; Brunclik V; Opatrilova R; Kolevska J; Mokry P; Kollar P; Strnadova V; Suchy P
    Eur J Pharmacol; 2007 Dec; 575(1-3):127-33. PubMed ID: 17706639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ventricular fibrillation in chronic heart disease].
    Pleskot M; Parízek P; Hodac M; Haman L; Stásek J; Cervinka P; Tauchman M
    Vnitr Lek; 2000 Feb; 46(2):80-6. PubMed ID: 11048528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of cicletanine on a sudden death model in dogs].
    Guillon JM; Thievant P; Braquet P
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():151-4. PubMed ID: 2514657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic drugs in the prevention of ventricular arrhythmias related to paired pacing.
    Rothfeld EL; Zucker IR; Tiu R; Parsonnet V
    Am J Cardiol; 1970 Jul; 26(1):52-5. PubMed ID: 5427832
    [No Abstract]   [Full Text] [Related]  

  • 40. Quinidine-A legacy within the modern era of antiarrhythmic therapy.
    Vitali Serdoz L; Rittger H; Furlanello F; Bastian D
    Pharmacol Res; 2019 Jun; 144():257-263. PubMed ID: 31026503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.